Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis

A 51-year-old man was admitted due to an acute anterior ST-segment elevation myocardial infarction. After thrombolytic therapy using recombinant tissue plasminogen activator, stent implantation was performed from the proximal left anterior descending artery (LAD) to the mid LAD using a bare-metal st...

Full description

Bibliographic Details
Main Authors: Hachinohe, Daisuke, Jeong, Myung Ho, Kim, Min Chol, Cho, Kyung Hoon, Ahmed, Khurshid, Hwang, Seung Hwan, Lee, Min Goo, Sim, Doo Sun, Park, Keun-Ho, Kim, Ju Han, Hong, Young Joon, Ahn, Youngkeun, Kang, Jung Chaee
Format: Online
Language:English
Published: The Korean Society of Cardiology 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242025/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242025/

Similar Items